Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Corcept Therapeutics › Officer reported a gift or transfer of 787 CORT shares Insider trades
Why it stands out Gift or transfer — classified separately from trades.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Dec 2, 2025
Reporting period Not applicable
Filed with the SEC Dec 4, 2025 Officer Indirect holding Gift / transfer
Context Classification gift transfer
Code G — gift, bequest or transfer
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
0001193125-25-307282
Filed / recorded Dec 4, 2025, 7:19 AM UTC
Added to OQRO Oct 6, 2026, 7:14 PM UTC
Data quality Verified: identifiers matched exactly
Issuer CORCEPT THERAPEUTICS INC
Reporting person William Guyer
Officer title Chief Development Officer
Table Non-derivative (Table I)
Transaction date Dec 2, 2025
Acquired / disposed Disposed (D)
Ownership form Indirect — The Lake Bainwood Living Trust
Footnotes from the filing Represents the shares held by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee.
Around the same time Insider filing
Traded Dec 24, 2025 · filed 6 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Dec 24, 2025 · filed 6 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Dec 24, 2025 · filed 6 days later
Derivative exercise or conversion — not an open-market buy.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Oct 6, 2025 Company filing · Form 8-K · Executive change Changed a top executive or board member “On October 6, 2025, Gillian Cannon, Ph.D., notified the Board of Directors (the “Board”) of Corcept Therapeutics Incorporated (the “Company”) of her resignation from the Board, effective as of October 10, 2025 (the “Effective Date”).” Oct 7, 2025 Insider Officer sold ~$1.8M of CORT shares in the open market Oct 10, 2025 Company filing · Form 8-K · Agreement ended Ended an important agreement Oct 10, 2025 Insider Director sold ~$193K of CORT shares in the open market Nov 3, 2025 Insider · 3 people Insiders: 3 sales (~$2.7M) Nov 4, 2025 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Nov 5, 2025 Insider · 2 people Insiders: 6 sales (~$3.7M) Nov 25, 2025 Insider · 1 person Insiders: 2 sales (~$728K) Dec 1, 2025 Insider · 3 people Insiders: 3 sales (~$5.2M) Dec 2, 2025 Insider · 1 person Insiders: 2 sales (~$1.6M) What came next Jan 6, 2026 Insider Officer sold ~$704K of CORT shares in the open market Feb 3, 2026 Insider Officer sold ~$817K of CORT shares in the open market Feb 24, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Mar 4, 2026 Insider Officer sold ~$296K of CORT shares in the open market
Mar 17, 2026